Please provide your email address to receive an email when new articles are posted on . Societies issued new guidelines for the screening and treatment of stroke. The new document provides ...
In January 2026, the American Heart and American Stroke Association (AHA/ASA) issued new care guidelines for acute ischemic stroke (AIS) patients. The entities' “2026 Guideline for the Early ...
In-hospital ischemic stroke poses unique challenges distinct from community-onset events. Patients already admitted for other conditions often have multiple comorbidities, sedative agents or ...
The new guideline endorses the use of either alteplase or tenecteplase in the 4.5-hour thrombolytic treatment window. HealthDay News — In a guideline issued by the American Heart Association/American ...
In this forward-looking finale, the panel discusses the transformative shifts expected in stroke management over the next five years. While the introduction of Factor XIa inhibitors like asundexian ...
HELSINKI, Finland — An artificial intelligence (AI)–based clinical decision support system helped doctors make decisions in the treatment of acute ischemic stroke and was associated with a significant ...
A recent study presented today at the Society of NeuroInterventional Surgery's (SNIS) 20th Annual Meeting noted that U.S. rates of endovascular thrombectomy, a lifesaving stroke treatment, are ...
BACKGROUND: Determining the source of thromboembolism in patients with acute ischemic stroke remains challenging because current diagnostic approaches rely largely on circumstantial and inferential ...
OCEANIC-STROKE shows asundexian cuts ischemic stroke recurrence by 26% in patients taking standard antiplatelet therapy, with no major bleeding increase. Asundexian is a direct oral inhibitor of FXIa ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results